Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial

BACKGROUND: Despite over 50 years of experience with adrenocorticotropic hormone (ACTH) as a treatment for acute exacerbations of multiple sclerosis, there have been no trials examining the options of the 2–3-week dosing regimen or intramuscular injection protocol used in the original trials. At our...

Descripción completa

Detalles Bibliográficos
Autores principales: Simsarian, James P, Saunders, Carol, Smith, D Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140290/
https://www.ncbi.nlm.nih.gov/pubmed/21792296
http://dx.doi.org/10.2147/DDDT.S19331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140290/
https://www.ncbi.nlm.nih.gov/pubmed/21792296
http://dx.doi.org/10.2147/DDDT.S19331

Ejemplares similares